Reuters: Regulatory News: India's Wockhardt gets U.S. nod for Parkinson's generic

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

India's Wockhardt gets U.S. nod for Parkinson's generic Aug 20th 2012, 08:00 MUMBAI | Mon Aug 20, 2012 4:00am EDT MUMBAI Aug 20 (Reuters) - Indian drugmaker Wockhardt Ltd said on Monday it has received approval from the U.S. Food and Drug Administration to sell Entacapone tablets, which are used in treatment of Parkinson's disease. Entacapone, which will be launched on Sept. 30 with a 180-day exclusive period, is the generic name for the brand Comtan, owned by Orion Corp., Wockhardt said in a statement on its website.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions